6.
Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S
. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010; 330(6005):841-5.
PMC: 3719181.
DOI: 10.1126/science.1194637.
View
7.
Kettenmann H, Hanisch U, Noda M, Verkhratsky A
. Physiology of microglia. Physiol Rev. 2011; 91(2):461-553.
DOI: 10.1152/physrev.00011.2010.
View
8.
Hirokawa N, Niwa S, Tanaka Y
. Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron. 2010; 68(4):610-38.
DOI: 10.1016/j.neuron.2010.09.039.
View
9.
Setou M, Nakagawa T, Seog D, Hirokawa N
. Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science. 2000; 288(5472):1796-802.
DOI: 10.1126/science.288.5472.1796.
View
10.
Morikawa M, Tanaka Y, Cho H, Yoshihara M, Hirokawa N
. The Molecular Motor KIF21B Mediates Synaptic Plasticity and Fear Extinction by Terminating Rac1 Activation. Cell Rep. 2018; 23(13):3864-3877.
DOI: 10.1016/j.celrep.2018.05.089.
View
11.
Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C
. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res. 2006; 42(2):151-7.
DOI: 10.1016/j.jpsychires.2006.10.013.
View
12.
Yoshihara S, Jiang X, Morikawa M, Ogawa T, Ichinose S, Yabe H
. Betaine ameliorates schizophrenic traits by functionally compensating for KIF3-based CRMP2 transport. Cell Rep. 2021; 35(2):108971.
DOI: 10.1016/j.celrep.2021.108971.
View
13.
Iwata S, Morikawa M, Takei Y, Hirokawa N
. An activity-dependent local transport regulation via degradation and synthesis of KIF17 underlying cognitive flexibility. Sci Adv. 2020; 6(51).
PMC: 7744090.
DOI: 10.1126/sciadv.abc8355.
View
14.
Krabbe G, Matyash V, Pannasch U, Mamer L, Boddeke H, Kettenmann H
. Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity. Brain Behav Immun. 2011; 26(3):419-28.
DOI: 10.1016/j.bbi.2011.12.002.
View
15.
Izuo N, Nitta A
. New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction. J Pers Med. 2021; 11(5).
PMC: 8147599.
DOI: 10.3390/jpm11050371.
View
16.
Alsabban A, Morikawa M, Tanaka Y, Takei Y, Hirokawa N
. Kinesin Kif3b mutation reduces NMDAR subunit NR2A trafficking and causes schizophrenia-like phenotypes in mice. EMBO J. 2019; 39(1):e101090.
PMC: 6939202.
DOI: 10.15252/embj.2018101090.
View
17.
Fernandez-Arjona M, Grondona J, Granados-Duran P, Fernandez-Llebrez P, Lopez-Avalos M
. Microglia Morphological Categorization in a Rat Model of Neuroinflammation by Hierarchical Cluster and Principal Components Analysis. Front Cell Neurosci. 2017; 11:235.
PMC: 5550745.
DOI: 10.3389/fncel.2017.00235.
View
18.
Kurihara M, Ishiura H, Bannai T, Mitsui J, Yoshimura J, Morishita S
. A Novel de novo KIF1A Mutation in a Patient with Autism, Hyperactivity, Epilepsy, Sensory Disturbance, and Spastic Paraplegia. Intern Med. 2019; 59(6):839-842.
PMC: 7118386.
DOI: 10.2169/internalmedicine.3661-19.
View
19.
Yilmaz M, Yalcin E, Presumey J, Aw E, Ma M, Whelan C
. Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice. Nat Neurosci. 2020; 24(2):214-224.
PMC: 8086435.
DOI: 10.1038/s41593-020-00763-8.
View
20.
Heneka M, Kummer M, Latz E
. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014; 14(7):463-77.
DOI: 10.1038/nri3705.
View